Biocardia announces positive preclinical results supporting investigational new drug application for anti-inflammatory cell therapy in heart failure

Biocardia announces positive preclinical results supporting investigational new drug application for anti-inflammatory cell therapy in heart failure.biocardia - planning further exploration & discussion with fda on use of its allogenic cells for covid-19 related acute respiratory distress syndrome.biocardia - intends to submit an ind for use of its nk1r+ msc delivered via iv infusion for ards caused by covid-19.
BCDA Ratings Summary
BCDA Quant Ranking